Related Experiment Videos
Essential fatty acid deficiency during acute puromycin nephrosis ameliorates late renal injury
J R Diamond1, I Pesek, S Ruggieri
1Department of Pathology, Harvard Medical School, Boston, Massachusetts.
Abstract:
Puromycin aminonucleoside (PA) nephrosis is associated with a significant increase in the glomerular macrophage number during peak proteinuria. The significance of this observation remains uncertain. An essential fatty acid-deficient (EFAD) diet depletes normal rat glomeruli of resident macrophages and alters glomerular eicosanoid metabolism. In this study, we found that an EFAD diet, administered only for the duration of the acute nephrotic phase, significantly ameliorated the recurrent albuminuria, renal dysfunction, and morphological injury characteristic of the late, recurrent phase of chronic aminonucleoside nephrosis. Glomerular macrophage number, isolated glomerular thromboxane B2 production, and circulating leukocyte and monocyte counts were significantly reduced in nephrotic rats on the EFAD diet 2 wk after PA injection, which temporally corresponds to peak albuminuria. The exact mechanism(s) by which the EFAD diet conferred protection in the late phase of chronic aminonucleoside nephrosis and lowered glomerular macrophage number during the acute nephrotic phase remain to be elucidated.
Insights
An essential fatty acid-deficient (EFAD) diet reduced proteinuria and kidney injury in puromycin aminonucleoside (PA) nephrosis. This diet also lowered macrophage counts and thromboxane B2 production during peak albuminuria.
Area of Science:
- Nephrology
- Immunology
- Nutritional Science
Background:
- Puromycin aminonucleoside (PA) nephrosis involves increased glomerular macrophages during proteinuria.
- The role of these macrophages in disease progression is unclear.
- Essential fatty acid-deficient (EFAD) diets alter macrophage populations and eicosanoid metabolism.
Purpose of the Study:
- To investigate the therapeutic potential of an EFAD diet in chronic aminonucleoside nephrosis.
- To determine if EFAD diet impacts macrophage infiltration and related markers during nephrosis.
Main Methods:
- Rats with chronic aminonucleoside nephrosis were fed an EFAD diet during the acute phase.
- Evaluated recurrent albuminuria, renal dysfunction, and kidney morphology.
- Measured glomerular macrophage numbers, thromboxane B2 production, and leukocyte/monocyte counts.
Main Results:
- EFAD diet administration during the acute phase ameliorated proteinuria, renal dysfunction, and injury in the late phase.
- Nephrotic rats on the EFAD diet showed reduced glomerular macrophages and thromboxane B2 levels.
- Circulating leukocyte and monocyte counts were also significantly lower in the EFAD group.
Conclusions:
- An EFAD diet can protect against chronic aminonucleoside nephrosis progression.
- The protective effects may be linked to reduced macrophage infiltration and altered eicosanoid metabolism.
- Further research is needed to elucidate the precise mechanisms of EFAD diet-induced protection.